<![CDATA[Pharma — November 2024]]>ALK-Abelló opnår rettigheder til næsespray mod allergisk shock https://proinvestor.com/investornyt/1240801/alk-abello-opnar-rettigheder-til-naesespray-mod-allergisk-shock

]]>https://dev.proinvestor.com/forum/topic/400892/pharma-november-2024RSS for NodeSun, 07 Jun 2026 08:12:06 GMTMon, 11 Nov 2024 05:07:51 GMT60<![CDATA[Reply to Pharma — November 2024 on Thu, 28 Nov 2024 07:51:46 GMT]]>Lundbeck-topchef: Sidste hurdle er fjernet i opkøb af Longboard https://proinvestor.com/investornyt/1248295/lundbeck-topchef-sidste-hurdle-er-fjernet-i-opkob-af-longboard

]]>https://dev.proinvestor.com/forum/post/8038188https://dev.proinvestor.com/forum/post/8038188Thu, 28 Nov 2024 07:51:46 GMT<![CDATA[Reply to Pharma — November 2024 on Wed, 27 Nov 2024 12:40:13 GMT]]>ALK-Abelló får offentliggjort vigtigt fase 3-studie i The Lancet https://proinvestor.com/investornyt/1247921/alk-abello-far-offentliggjort-vigtigt-fase-3-studie-i-the-lancet

]]>https://dev.proinvestor.com/forum/post/8038189https://dev.proinvestor.com/forum/post/8038189Wed, 27 Nov 2024 12:40:13 GMT<![CDATA[Reply to Pharma — November 2024 on Wed, 27 Nov 2024 11:19:53 GMT]]>Lundbeck indleder senfase-studie for middel til behandling af sjælden neurologisk lidelse https://proinvestor.com/investornyt/1247800/lundbeck-indleder-senfase-studie-for-middel-til-behandling-af-sjaelden-neurologisk-lidelse

]]>https://dev.proinvestor.com/forum/post/8038186https://dev.proinvestor.com/forum/post/8038186Wed, 27 Nov 2024 11:19:53 GMT<![CDATA[Reply to Pharma — November 2024 on Fri, 22 Nov 2024 05:13:11 GMT]]>Which Is A Better Pick: JNJ Stock Or ABBV Stock?https://proinvestor.com/investornyt/1245930/which-is-a-better-pick-jnj-stock-or-abbv-stock

]]>https://dev.proinvestor.com/forum/post/8038190https://dev.proinvestor.com/forum/post/8038190Fri, 22 Nov 2024 05:13:11 GMT<![CDATA[Reply to Pharma — November 2024 on Thu, 21 Nov 2024 12:40:43 GMT]]>Kort video: Novo Nordisk, Genmab, NVIDIA

Fredag i sidste uge fik de danske lifescience-aktier bank, efter Trump indstillede vaccine- og fedmemedicinmodstander Robert F. Kennedy som sundhedsminister. Men er der grund til at være så nervøs? Så er der kommet en tidshorisont fra Genmab i forhold til Hexabody og Jansen. Og så forklarer Helge Larsen, hvorfor NVIDIA er én af de aktier, han tror mest på de næste 12 måneder. https://proinvestor.com/boards/123112

]]>https://dev.proinvestor.com/forum/post/8038185https://dev.proinvestor.com/forum/post/8038185Thu, 21 Nov 2024 12:40:43 GMT<![CDATA[Reply to Pharma — November 2024 on Thu, 21 Nov 2024 04:47:31 GMT]]>Godmorgen 🙂

]]>https://dev.proinvestor.com/forum/post/8038183https://dev.proinvestor.com/forum/post/8038183Thu, 21 Nov 2024 04:47:31 GMT<![CDATA[Reply to Pharma — November 2024 on Wed, 20 Nov 2024 14:36:08 GMT]]>Regnskabssæsonen er næsten ovre, og det er tid til at gøre status over de store, danske selskaber. Hvem er bestået? Er der nogen, der er dumpet? Det ser Hansen og Larsen nærmere på. De ser også på den danske life science sektor, der er hårdt prøvet for tiden. Om lidt præsenterer Novo Nordisk data om Cagrisema - hvad betyder det for casen på kort og lang sigt? Og så er Bavarian sendt 'hjem' efter en nedtur på 15%. Er drømmen kollapset? https://proinvestor.com/boards/123091

]]>https://dev.proinvestor.com/forum/post/8038187https://dev.proinvestor.com/forum/post/8038187Wed, 20 Nov 2024 14:36:08 GMT<![CDATA[Reply to Pharma — November 2024 on Mon, 18 Nov 2024 13:24:58 GMT]]>Er der noget nyt omkring BerGenBio siden den skyder op med 53%?

]]>https://dev.proinvestor.com/forum/post/8038180https://dev.proinvestor.com/forum/post/8038180Mon, 18 Nov 2024 13:24:58 GMT<![CDATA[Reply to Pharma — November 2024 on Mon, 18 Nov 2024 05:02:21 GMT]]>Aktier: Dansk life science nedtur: Bliver USA rask af en ny sundhedsminister? https://proinvestor.com/boards/123063

]]>https://dev.proinvestor.com/forum/post/8038191https://dev.proinvestor.com/forum/post/8038191Mon, 18 Nov 2024 05:02:21 GMT<![CDATA[Reply to Pharma — November 2024 on Fri, 15 Nov 2024 05:34:15 GMT]]>ALK-Abelló får løftet kursmålet af SEB efter regnskab https://proinvestor.com/investornyt/1243160/alk-abello-far-loftet-kursmalet-af-seb-efter-regnskab

]]>https://dev.proinvestor.com/forum/post/8038182https://dev.proinvestor.com/forum/post/8038182Fri, 15 Nov 2024 05:34:15 GMT<![CDATA[Reply to Pharma — November 2024 on Fri, 15 Nov 2024 05:11:23 GMT]]>Trump taps RFK Jr. for HHS role, rattling vaccine stocks https://firstwordpharma.com/story/5912647

]]>https://dev.proinvestor.com/forum/post/8038181https://dev.proinvestor.com/forum/post/8038181Fri, 15 Nov 2024 05:11:23 GMT<![CDATA[Reply to Pharma — November 2024 on Fri, 15 Nov 2024 05:04:50 GMT]]>Godmorgen 🙂

]]>https://dev.proinvestor.com/forum/post/8038179https://dev.proinvestor.com/forum/post/8038179Fri, 15 Nov 2024 05:04:50 GMT<![CDATA[Reply to Pharma — November 2024 on Thu, 14 Nov 2024 15:56:40 GMT]]>Myndigheder skifter mening og anbefaler middel mod Alzheimer - aktie stiger https://proinvestor.com/investornyt/1242939/myndigheder-skifter-mening-og-anbefaler-middel-mod-alzheimer-aktie-stiger

]]>https://dev.proinvestor.com/forum/post/8038177https://dev.proinvestor.com/forum/post/8038177Thu, 14 Nov 2024 15:56:40 GMT<![CDATA[Reply to Pharma — November 2024 on Thu, 14 Nov 2024 13:51:14 GMT]]>Kort videoopdatering: Gubra, Zealand Pharma, Anavex, Genmab, ALK-Abelló, Lundbeck, Novo Nordisk https://proinvestor.com/boards/123020/

]]>https://dev.proinvestor.com/forum/post/8038173https://dev.proinvestor.com/forum/post/8038173Thu, 14 Nov 2024 13:51:14 GMT<![CDATA[Reply to Pharma — November 2024 on Thu, 14 Nov 2024 10:14:14 GMT]]>ALK/børshuse: Stærkt tabletsalg og driftsindtjening stikker ud https://proinvestor.com/investornyt/1242684/alk-borshuse-staerkt-tabletsalg-og-driftsindtjening-stikker-ud

]]>https://dev.proinvestor.com/forum/post/8038176https://dev.proinvestor.com/forum/post/8038176Thu, 14 Nov 2024 10:14:14 GMT<![CDATA[Reply to Pharma — November 2024 on Thu, 14 Nov 2024 08:27:06 GMT]]>ALK's topchef om fordoblet driftsindtjening: Optimeringer og stærkt tabletsalg løfter https://proinvestor.com/investornyt/1242634/alks-topchef-om-fordoblet-driftsindtjening-optimeringer-og-staerkt-tabletsalg-lofter

]]>https://dev.proinvestor.com/forum/post/8038169https://dev.proinvestor.com/forum/post/8038169Thu, 14 Nov 2024 08:27:06 GMT<![CDATA[Reply to Pharma — November 2024 on Thu, 14 Nov 2024 07:09:33 GMT]]>ALK-Abello: Fornemt arbejde https://proinvestor.com/boards/123019

]]>https://dev.proinvestor.com/forum/post/8038184https://dev.proinvestor.com/forum/post/8038184Thu, 14 Nov 2024 07:09:33 GMT<![CDATA[Reply to Pharma — November 2024 on Thu, 14 Nov 2024 07:02:52 GMT]]>ALK-Abelló OVERBLIK Q3: Bedre end ventet på både top og bund https://proinvestor.com/investornyt/1242611/alk-abello-overblik-q3-bedre-end-ventet-pa-bade-top-og-bund

]]>https://dev.proinvestor.com/forum/post/8038174https://dev.proinvestor.com/forum/post/8038174Thu, 14 Nov 2024 07:02:52 GMT<![CDATA[Reply to Pharma — November 2024 on Thu, 14 Nov 2024 05:27:17 GMT]]>Lundbeck får løftet kursmålet hos Nordea efter regnskab https://proinvestor.com/investornyt/1242605/lundbeck-far-loftet-kursmalet-hos-nordea-efter-regnskab

]]>https://dev.proinvestor.com/forum/post/8038170https://dev.proinvestor.com/forum/post/8038170Thu, 14 Nov 2024 05:27:17 GMT<![CDATA[Reply to Pharma — November 2024 on Wed, 13 Nov 2024 10:56:05 GMT]]>Lundbeck leverer endnu et stærkt vækstkvartal og holder dampen oppe frem mod patentudløb https://proinvestor.com/investornyt/1242113/lundbeck-leverer-endnu-et-staerkt-vaekstkvartal-og-holder-dampen-oppe-frem-mod-patentudlob

]]>https://dev.proinvestor.com/forum/post/8038178https://dev.proinvestor.com/forum/post/8038178Wed, 13 Nov 2024 10:56:05 GMT<![CDATA[Reply to Pharma — November 2024 on Wed, 13 Nov 2024 06:30:04 GMT]]>Lundbeck skruer endnu en gang op for forventningerne efter godt tredje kvartal https://proinvestor.com/investornyt/1242075/lundbeck-skruer-endnu-en-gang-op-for-forventningerne-efter-godt-tredje-kvartal

]]>https://dev.proinvestor.com/forum/post/8038172https://dev.proinvestor.com/forum/post/8038172Wed, 13 Nov 2024 06:30:04 GMT<![CDATA[Reply to Pharma — November 2024 on Wed, 13 Nov 2024 04:41:55 GMT]]>What's Happening With AbbVie Stock? https://proinvestor.com/investornyt/1242056/whats-happening-with-abbvie-stock

]]>https://dev.proinvestor.com/forum/post/8038175https://dev.proinvestor.com/forum/post/8038175Wed, 13 Nov 2024 04:41:55 GMT<![CDATA[Reply to Pharma — November 2024 on Mon, 11 Nov 2024 05:30:52 GMT]]>ALK/Jefferies: Licens til spray mod allergisk shock er attraktiv med klare synergier https://proinvestor.com/investornyt/1240805/alk-jefferies-licens-til-spray-mod-allergisk-shock-er-attraktiv-med-klare-synergier

]]>https://dev.proinvestor.com/forum/post/8038171https://dev.proinvestor.com/forum/post/8038171Mon, 11 Nov 2024 05:30:52 GMT